Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Conditional ablation of CD205+ conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo.

Fukaya T, Murakami R, Takagi H, Sato K, Sato Y, Otsuka H, Ohno M, Hijikata A, Ohara O, Hikida M, Malissen B, Sato K.

Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11288-93. doi: 10.1073/pnas.1202208109. Epub 2012 Jun 26.

2.

Analysis of DC Functions Using CD205-DTR Knock-In Mice.

Fukaya T, Takagi H, Uto T, Arimura K, Sato K.

Methods Mol Biol. 2016;1423:291-308. doi: 10.1007/978-1-4939-3606-9_21.

PMID:
27142025
3.

CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.

Njongmeta LM, Bray J, Davies CJ, Davis WC, Howard CJ, Hope JC, Palmer GH, Brown WC, Mwangi W.

Vaccine. 2012 Feb 21;30(9):1624-35. doi: 10.1016/j.vaccine.2011.12.110. Epub 2012 Jan 10.

PMID:
22240344
4.

CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self.

Shrimpton RE, Butler M, Morel AS, Eren E, Hue SS, Ritter MA.

Mol Immunol. 2009 Mar;46(6):1229-39. doi: 10.1016/j.molimm.2008.11.016. Epub 2009 Jan 8.

5.

Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.

Kamphorst AO, Guermonprez P, Dudziak D, Nussenzweig MC.

J Immunol. 2010 Sep 15;185(6):3426-35. doi: 10.4049/jimmunol.1001205. Epub 2010 Aug 20.

6.

Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity.

Uto T, Fukaya T, Takagi H, Arimura K, Nakamura T, Kojima N, Malissen B, Sato K.

Nat Commun. 2016 Apr 12;7:11273. doi: 10.1038/ncomms11273.

7.

The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells.

Henning P, Gustafsson T, Flach CF, Hua YJ, Strömbeck A, Holmgren J, Lindholm L, Yrlid U.

Eur J Immunol. 2011 Aug;41(8):2185-96. doi: 10.1002/eji.201041009. Epub 2011 Jul 6.

9.

Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.

Flacher V, Tripp CH, Haid B, Kissenpfennig A, Malissen B, Stoitzner P, Idoyaga J, Romani N.

J Immunol. 2012 Mar 1;188(5):2146-55. doi: 10.4049/jimmunol.1004120. Epub 2012 Jan 30.

10.

Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo.

Takagi H, Fukaya T, Eizumi K, Sato Y, Sato K, Shibazaki A, Otsuka H, Hijikata A, Watanabe T, Ohara O, Kaisho T, Malissen B, Sato K.

Immunity. 2011 Dec 23;35(6):958-71. doi: 10.1016/j.immuni.2011.10.014. Epub 2011 Dec 15.

11.

CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.

Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, Inaba K, Nussenzweig MC, Steinman RM.

J Immunol. 2008 Nov 15;181(10):6923-33.

12.

A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.

Soares H, Waechter H, Glaichenhaus N, Mougneau E, Yagita H, Mizenina O, Dudziak D, Nussenzweig MC, Steinman RM.

J Exp Med. 2007 May 14;204(5):1095-106. Epub 2007 Apr 16.

13.

The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.

Wang B, Kuroiwa JM, He LZ, Charalambous A, Keler T, Steinman RM.

Ann N Y Acad Sci. 2009 Sep;1174:6-17. doi: 10.1111/j.1749-6632.2009.04933.x.

14.

Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets.

Kastenmüller K, Wille-Reece U, Lindsay RW, Trager LR, Darrah PA, Flynn BJ, Becker MR, Udey MC, Clausen BE, Igyarto BZ, Kaplan DH, Kastenmüller W, Germain RN, Seder RA.

J Clin Invest. 2011 May;121(5):1782-96. doi: 10.1172/JCI45416. Epub 2011 Apr 11.

15.

Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Zhou F, Lauretti E, di Meco A, Ciric B, Gonnella P, Zhang GX, Rostami A.

Immunobiology. 2013 Aug;218(8):1069-76. doi: 10.1016/j.imbio.2013.02.003. Epub 2013 Mar 1.

16.

Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.

Shakhar G, Lindquist RL, Skokos D, Dudziak D, Huang JH, Nussenzweig MC, Dustin ML.

Nat Immunol. 2005 Jul;6(7):707-14. Epub 2005 May 29.

17.

Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.

Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S.

J Immunol. 2011 Jan 15;186(2):1218-27. doi: 10.4049/jimmunol.1000808. Epub 2010 Dec 13.

18.

Differential antigen processing by dendritic cell subsets in vivo.

Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, Cheong C, Liu K, Lee HW, Park CG, Steinman RM, Nussenzweig MC.

Science. 2007 Jan 5;315(5808):107-11.

19.

Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.

Keller AM, Schildknecht A, Xiao Y, van den Broek M, Borst J.

Immunity. 2008 Dec 19;29(6):934-46. doi: 10.1016/j.immuni.2008.10.009. Epub 2008 Dec 8.

20.

Supplemental Content

Support Center